JP
Jagat Parkash
About Jagat Parkash
Data last updated:
Jagat Parkash is a Director at Fibovil Pharmaceuticals Private Limited (since 2022) and Director at Cafoli Lifecare Private Limited (since 2024). The companies operate in Pharma and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹37.71 Cr; the largest is Fibovil Pharmaceuticals Private Limited at ₹36.82 Cr (FY 2025). Earlier, Jagat Parkash was a Director at Covaxl Pharmaceuticals Private Limited (from 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fibovil Pharmaceuticals Private Limited U24239HR2019PTC079733 | Director | 20 Jun 2022 | 2019 | ₹36.82 Cr (FY 2025) | Active |
 Cafoli Lifecare Private Limited U21002HR2024PTC124200 | Director | 13 Aug 2024 | 2024 | ₹89 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Covaxl Pharmaceuticals Private Limited U46497HR2023PTC112227 | Director | 02 Jun 2023 | 2023 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jagat Parkash
| Name | DIN | Company | Designation |
|---|---|---|---|
| Reetu Rani | 08421066 | Fibovil Pharmaceuticals Private Limited , Cafoli Lifecare Private Limited | Director |
| Sahil | 08421065 | Fibovil Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jagat Parkash
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jagat Parkash
Jagat Parkash currently holds 2 directorships: Fibovil Pharmaceuticals Private Limited (Director, since 20 Jun 2022, revenue ₹36.82 Cr (FY 2025)); Cafoli Lifecare Private Limited (Director, since 13 Aug 2024, revenue ₹89 Lakh (FY 2025)).
Jagat Parkash was first appointed on 20 Jun 2022 as Director at Fibovil Pharmaceuticals Private Limited. The most recent appointment on record is 13 Aug 2024 at Cafoli Lifecare Private Limited.
The 2 current companies of Jagat Parkash that report revenue have a combined latest revenue of ₹37.71 Cr: Fibovil Pharmaceuticals Private Limited ₹36.82 Cr (FY 2025); Cafoli Lifecare Private Limited ₹89 Lakh (FY 2025).
Jagat Parkash held 1 earlier board appointment: Covaxl Pharmaceuticals Private Limited (Director, from 02 Jun 2023).
The current boards of Jagat Parkash's companies include Reetu Rani (Fibovil Pharmaceuticals Private Limited), Sahil (Fibovil Pharmaceuticals Private Limited).